ArticleFrontiers in immunology2024

Biomarkers and potential therapeutic targets driving progression of non-alcoholic steatohepatitis to hepatocellular carcinoma predicted through transcriptomic analysis.

Hui Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.